Home

24Oct 2018

Real-world evidence (RWE) research is gaining significant importance in biopharmaceutical product development as well as its commercialization. The increasing need of the industry to seek broader information about the safety and effectiveness in the real-world setting, which typically impacts the ensuing reimbursement and utilization of new products, is determined by regulators, public and private payers, […]

04Oct 2018

India is in the middle of health transformation. Although infectious diseases like tuberculosis, malaria, dengue, H1N1 pandemic influenza and antimicrobial resistance continue to pose health and economic burden, the country is also facing challenges with chronic non-communicable diseases, such as cardiovascular diseases, diabetes, cancer; which are the leading cause of mortality. Social and economic determinants […]

22Sep 2018

The discipline of ‘health economics’ has significantly progressed to become more inclusive, beginning with only cost-benefit analyses of public health programs, such as vaccinations, to evolving into a large area of health technology assessments (HTA). Cost-effectiveness analyses are a routine practice in HTA and are performed virtually for every new health technology. Healthcare industry as […]

13Aug 2018

Network meta-analysis (NMA) is a type of meta-analysis that adds an additional variable to a meta-analysis, and instead of a simple summation of trials that have evaluated the same treatment, several different treatments are compared by statistical inference.1 NMA is also referred to as mixed treatments comparison or multiple treatments comparison meta-analysis.2,3,4 It was recognised […]

03Aug 2018

There are humungous quantities of data existing in healthcare; data from all kinds of sources, such as clinical, patient, payer, R&D, pharmacy as well as revolutionary technologies that are being quickly embraced, for e.g. data from wearable devices. According to a report by International Data Corporation (IDC), (1) the volume of healthcare data which was observed […]

24Jul 2018

Traditionally, systematic reviews are considered as the gold standard to inform clinical practice and policy decisions. However, systematic reviews are resource and time intensive. The time factor has been identified as a barrier to implementing results from evidence synthesis, as a result of an incongruence between the time required to produce a full systematic review […]

12Jul 2018

Heath Technology Assessment (HTA) is a scientific research area that makes informed clinical as well as policy decisions on the use of health technologies, which include pharmaceuticals, medical devices, diagnostics, procedures and other clinical, public health and organizational interventions. (1) Recently, ‘early HTA’ is progressively being promoted as a perspective to determine added value of […]

10Jul 2018

The concept of “Big Data” is #trending today, which is characterized by types of data sources with huge quantities, high speed and broad diversity of information. Healthcare industries are trying to apply Big Data analytics to reform data into a workable platform in order to generate information that would help making better and faster clinical […]

03Jul 2018

In recent years, patient-centric initiatives are becoming key factors among healthcare companies, as they are increasingly becoming aware of the fact that the key to growing business and improving customer health is to better focus on the needs and concerns of the patient, rather than attending to just the product approval. The objective behind patient-centric drug […]